MapLight Therapeutics, Inc. Common Stock (MPLT)
Healthcare
Biotechnology
—
12.60 $
-3.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of MapLight Therapeutics, Inc. Common Stock (MPLT) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/03/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/30/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/27/2026 | Current report (8-K) | MapLight Therapeutics, Inc. (MPLT): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View report → |
| 07/17/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/17/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
| 07/15/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
Showing the 100 most recent filings of the selected type.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.